SEO TAG
CONTACT
SSY Group Limited
SSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products and medical packaging materials. It ranks among the top 100 enterprises in China's pharmaceutical industry and the excellent export-oriented enterprises in chemical and pharmaceutical industry preparation. In 2007, the company waslisted on the main board of Hong Kong (SSY Group Limited, 02005.HK).
-
10
The Group has 10 subsidiaries
-
4800
The Group has 4800 employees
-
74
Assets of 7.4 billion RMB
-
30
Annual production capacity of injection has attained 3 billion(ampoule/bottle/bag)
-
60
Main business income has reached 6 billion RMB
News Center
There is currently no information to display
Energizing industry optimization, intelligent upgrading and green development
09/03/2022
Pursue "green" and integrate development
08/17/2022
Innovation leads the cohesion "butterfly change"
08/15/2022
2022-09-07
Polypropylene infusion bottle packaging metronidazole sodium chloride injection approved
After obtaining the approval documents for the production of Agatroban API and the first approved azithromycin dry suspension in China, Shijiazhuang No.4 Pharmaceutical Group achieved another success in product development.
See more
2022-09-07
SJZ No.4 Pharmaceutical Agatroban API approved
Recently, Agatroban, which was declared by Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang No.4 Pharmaceutical Group, was approved by the State Drug Administration to be registered as an API for listed preparations.
See more
2022-09-05
Azithromycin dry suspension was approved for the first time in China
Recently, the azithromycin dry suspension developed by Shijiazhuang No.4 Pharmaceutical Co., Ltd. obtained the drug registration certificate issued by the State Drug Administration
See more
-
Technological Innovation Demonstration Enterprises recognized by the Ministry of Industry and Information Technology and the Ministry of Finance
-
Enterprise Technology Center recognized by Five Ministries and Commissions including the National Development and Reform Commission.
-
Post-Doctoral Research Center
-
Research unit of major national science and technology projects
-
National and local joint engineering laboratory
-
Large-volume injection engineering technology research center
-
Injection drug delivery system engineering technology research center
00:01:37
药物研究院片段2
Time of issue:
2022/02/17
Lead The Future By Innovation
SSY Group Limited aims to become one of the “first echelon of pharmaceutical innovation” companies.
And it promotes the cause of human health with strength from China!
PRODUCTS
-
The whole industrial chain from characteristic APIs and new preparations to the R&D, production and application of drug packaging materials -
Respiratory System -
Systemic Anti Infective Drugs -
Digestive Tract And Metabolism -
Cardiovascular System -
Blood And Hematopoietic Organs -
Medical Solution -
Central Nervous System -
Invigorate And Soothe The Nerves -
Drug Substance -
Medical Packaging Materials -
Cosmetic Products -
All Products
To promote the cause of human health with strength from China
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Copyright © 2021 SJZ No.4 Pharmaceutical 冀ICP备05007979号-1